Scientists Unveil Safer Way To Treat Inflammatory Eye Diseases
A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...
Cure Today2 天
GI Bleeding Significantly Impacts GIST Treatment Outcomes
The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.
Taiwan News1 天
Ryoncil® FDA Approval and Market Launch Highlighted at Tandem Transplantation Meetings
Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...
Morningstar29 天
First FDA-Approved Mesenchymal Stromal Cell Therapy Ushers in a New Era of Regenerative ...
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft ...
EurekAlert!4 天
Ocular graft-versus-host disease (GVHD) is common in patients with GVHD due to systemic ...
Researchers from Japan have found that treatment with mesenchymal stromal cells (MSCs) increased regulatory T cells while decreasing inflammatory TH1 and TH17 cells, highlighting MSCs' potential as a ...
来自MSN24 天
New imaging protocol enhances visualization of rare bone marrow cells
Bone marrow plays a crucial role in maintaining hematopoietic stem cells and bone homeostasis. However, research has been hindered by a lack of effective markers and monoclonal antibodies to ...